Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1

J Pediatr. 2023 Sep:260:113513. doi: 10.1016/j.jpeds.2023.113513. Epub 2023 May 25.

Abstract

Objective: To assess the hypothesis that plexiform neurofibroma (PN) growth rates increase during puberty.

Study design: PN growth rates before and during puberty were compared in a retrospective cohort of children with neurofibromatosis type 1 with puberty defined by Tanner staging. Of 33 potentially eligible patients, 25 had adequate quality magnetic resonance imaging for volumetric analysis and were included in ≥1 anchor cohort. Volumetric analysis was performed for all available imaging studies within the 4 years before and after puberty, and before and after 9- and 11-year-old anchor scans. Linear regression was performed to estimate the slope of change (PN growth rate); growth rates were compared with paired t test or Wilcoxon matched-pairs signed rank test.

Results: There were no significant difference in rates of PN growth in milliliters per month or milliliters per kilogram per month in the prepubertal vs pubertal periods (mean, 1.33 ± 1.67 vs 1.15 ± 1.38 [P = .139] and -0.003 ± 0.015 vs -0.002 ± 0.02 [P = .568]). Percent increases of PN volumes from baseline per month were significantly higher prepubertally (1.8% vs 0.84%; P = .041) and seemed to be related inversely to advancing age.

Conclusions: Puberty and its associated hormonal changes do not seem to influence PN growth rate. These findings support those previously reported, but from a typical population of children with neurofibromatosis type 1 with puberty confirmed by Tanner staging.

Keywords: cancer epidemiology; magnetic resonance imaging; nerve sheath tumor.

MeSH terms

  • Child
  • Cohort Studies
  • Humans
  • Neurofibroma, Plexiform*
  • Neurofibromatosis 1* / complications
  • Puberty
  • Retrospective Studies